Education
About Us
Working with TipRanks
Follow Us
Applied Therapeutics Inc (APLT)
NASDAQ:APLT
See the Price Targets and Ratings of:
APLT Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
William Blair
―
Hold
―
Downgraded
12/23/24
William Blair downgrades Applied Therapeutics (APLT) to a Hold
Leerink Partners
―
Buy
―
Reiterated
12/20/24
Analysts Are Bullish on Top Healthcare Stocks: Oruka Therapeutics (ORKA), Vertex Pharmaceuticals (VRTX)
RBC Capital
$4→$1.5
Hold
172.73%
Upside
Reiterated
12/20/24
RBC Capital Sticks to Their Hold Rating for Applied Therapeutics (APLT)
Citi
$8
Buy
1354.55%
Upside
Assigned
11/29/24
Applied Therapeutics price target raised to $13 from $11 at CitiApplied Therapeutics price target raised to $13 from $11 at Citi
Robert W. Baird
$14→$5
Buy
809.09%
Upside
Reiterated
11/29/24
Applied Therapeutics price target lowered to $5 from $14 at BairdApplied Therapeutics price target lowered to $5 from $14 at Baird
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
William Blair
―
Hold
―
Downgraded
12/23/24
William Blair downgrades Applied Therapeutics (APLT) to a Hold
Leerink Partners
―
Buy
―
Reiterated
12/20/24
Analysts Are Bullish on Top Healthcare Stocks: Oruka Therapeutics (ORKA), Vertex Pharmaceuticals (VRTX)
RBC Capital
$4→$1.5
Hold
172.73%
Upside
Reiterated
12/20/24
RBC Capital Sticks to Their Hold Rating for Applied Therapeutics (APLT)
Citi
$8
Buy
1354.55%
Upside
Assigned
11/29/24
Applied Therapeutics price target raised to $13 from $11 at CitiApplied Therapeutics price target raised to $13 from $11 at Citi
Robert W. Baird
$14→$5
Buy
809.09%
Upside
Reiterated
11/29/24
Applied Therapeutics price target lowered to $5 from $14 at BairdApplied Therapeutics price target lowered to $5 from $14 at Baird
APLT Analyst Recommendation Trends
Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
8
7
5
5
3
Buy
1
3
4
8
8
Hold
0
0
0
1
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
10
9
14
15
Each month's total comprises the sum of three months' worth of ratings.
APLT Stock Forecast FAQ
What is APLT’s average 12-month price target, according to analysts?
Based on analyst ratings, Applied Therapeutics Inc’s 12-month average price target is $1.50.
What is APLT’s upside potential, based on the analysts’ average price target?
Applied Therapeutics Inc has 172.73% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is APLT a Buy, Sell or Hold?
Applied Therapeutics Inc has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Applied Therapeutics Inc’s price target?
The average price target for Applied Therapeutics Inc is $1.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1.50 ,the lowest forecast is $1.50. The average price target represents 172.73% Increase from the current price of $0.55.
The highest analyst price target is $1.50 ,the lowest forecast is $1.50. The average price target represents 172.73% Increase from the current price of $0.55.
What do analysts say about Applied Therapeutics Inc?
Applied Therapeutics Inc’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of APLT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.